- Home
- CELU
CELU
Celularity Inc.
as 07-26-2024 4:00pm EST
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | FLORHAM PARK |
| Market Cap: | 67.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 19.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.59 - $7.97 | Next Earning Date: | 08-10-2024 |
| Revenue: | $14,788,000 | Revenue Growth: | -20.93% |
| Revenue Growth (this year): | 255.59% | Revenue Growth (next year): | -68.68% |
Latest Celularity Inc. News
CELU Breaking Stock News: Dive into CELU Ticker-Specific Updates for Smart Investing
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Bloomberg
2 months ago
Macron Calls French Legislative Election After Far-Right Surge
AFP
2 months ago
Trump loyalists proud to support 'felon' at Las Vegas rally
Business Insider
2 months ago
US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
Insider Monkey
2 months ago
The Best Woody Perfume For Women
Reuters
2 months ago
Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
Compare CELU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CELU Celularity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.